Earnings Feed
Start Free
Home/Filings/4/0000950142-22-002108
4//SEC Filing

Weiner Howard L. 4

Accession 0000950142-22-002108

CIK 0001641489other
View on SEC.govCompany Profile

Filed

Jul 5, 8:00 PM ET

Accepted

Jul 6, 4:14 PM ET

Size

11.5 KB

Accession

0000950142-22-002108

Insider Transaction Report

Form 4
Period: 2022-07-01
vTv Therapeutics Inc.VTVT
Weiner Howard L.
Director
Transactions
  • Award

    Director stock option (right to buy)

    2022-07-01+105,128→ 105,128 total
    Exercise: $0.72Exp: 2032-07-01→ Class A Common Stock (105,128 underlying)
Holdings

  • Director stock option (right to buy)

    Exercise: $1.79Exp: 2028-04-30→ Class A Common Stock (26,250 underlying)
    26,250

  • Director stock option (right to buy)

    Exercise: $1.45Exp: 2029-04-29→ Class A Common Stock (15,000 underlying)
    15,000

  • Director stock option (right to buy)

    Exercise: $2.54Exp: 2031-05-03→ Class A Common Stock (15,000 underlying)
    15,000

  • Director stock option (right to buy)

    Exercise: $2.65Exp: 2030-06-11→ Class A Common Stock (15,000 underlying)
    15,000
Footnotes (6)
  • [F1]An option to purchase 80,128 shares vested immediately on July 1, 2022. The remaining option to purchase 25,000 shares vests on June 1, 2023.
  • [F2]On May 2, 2018, May 1, 2019, June 15, 2020 and May 5, 2021, the reporting person filed Form 4s which inadvertently aggregated options to purchase shares of Class A common stock with different exercise prices and expiration dates. These errors have been corrected in the options beneficially owned in this Form 4.
  • [F3]An option to purchase 2,813 shares vested immediately on April 30, 2018. The remaining option to purchase 23,437 shares vests in equal monthly installments over the three-year period beginning on April 30, 2018.
  • [F4]Vests in equal monthly installments over the three-year period beginning April 29, 2019.
  • [F5]Vests in equal monthly installments over the three-year period beginning June 11, 2020.
  • [F6]Vests in equal monthly installments over the three-year period beginning May 3, 2021.

Documents

1 file

Issuer

vTv Therapeutics Inc.

CIK 0001641489

→
Entity typeother

Related Parties

1
  • filerCIK 0001710056

Filing Metadata

Form type
4
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 4:14 PM ET
Size
11.5 KB
View on SEC.gov